FORM DEF 14A

Company

LIPELLA PHARMACEUTICALS INC.

Filed

October 10, 2023

Period of Report

November 21, 2023

Accession Number

0001753926-23-001309

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →